Summary
Overview
Work History
Education
Skills
Certification
Timeline
Generic

Eric Haines

Andover,MA

Summary

Professional with robust background in directing and managing large-scale operations, consistently driving success through strategic planning and execution. Adept at implementing innovative solutions that enhance productivity and operational effectiveness. Known for fostering teamwork and adapting to evolving business needs, ensuring alignment with organizational goals.

Overview

11
11
years of professional experience
1
1
Certification

Work History

Director of Biology

Serna Bio
07.2024 - 02.2025
  • Managed cross-functional teams and external partnerships to advance research programs in oncology and rare diseases, aligning scientific goals with broader strategic objectives.
  • Led project planning and execution, coordinating with contract research organizations and academic partners to meet key milestones and improve program efficiency.
  • Designed and implemented strategic screening and data analysis processes to guide decision-making—demonstrating strong analytical, organizational, and problem-solving abilities.
  • Collaborated across departments to ensure alignment of research priorities with corporate strategy, showcasing effective communication and leadership in high-stakes environments.

Scientific Director of Cancer Biology

Ikena Oncology
11.2021 - 12.2024
  • Led cross-functional teams and external collaborators to advance drug development programs from discovery through clinical readiness, applying structured project management and strategic planning.
  • Built and managed a high-performing team of 4 scientists, guiding data-driven research initiatives and supporting key business decisions through analytical insight.
  • Directed multi-party research efforts, including experimental design, performance evaluation, and competitor analysis—demonstrating strong leadership, critical thinking, and operational coordination aligned with business goals.
  • Translated complex technical findings into actionable insights, supporting internal strategy discussions and cross-departmental initiatives.

Principal Scientist Discovery, Research, and Evaluation

Corbus Pharmaceuticals
04.2021 - 11.2021
  • Led a strategic company pivot to oncology, managing preclinical development of key assets, including pharmacology, biomarker discovery, and clinical assay planning.
  • Oversaw external partnerships with contract research organizations and academic collaborators to drive lead programs through regulatory studies under accelerated timelines.
  • Conducted in-depth due diligence for acquisition opportunities, performing comprehensive scientific and strategic evaluations that led to the successful acquisition of two assets.
  • Demonstrated strong analytical, project management, and cross-functional coordination skills applicable to financial and strategic decision-making.

Principal Scientist Immune Oncology

Bicycle Therapeutics
04.2018 - 04.2021
  • Led cross-functional initiatives to support strategic development of high-impact therapeutic programs, coordinating project timelines, resources, and stakeholder communication across teams.
  • Managed and mentored a team of 10 scientists, aligning project goals with broader organizational priorities and improving operational efficiency through streamlined processes.
  • Designed and optimized evaluation frameworks to assess program progress, enabling faster decision-making and improved pipeline advancement.
  • Collaborated with internal leadership and external partners to analyze complex datasets, identify performance trends, and support evidence-based planning for clinical and regulatory milestones.
  • Conducted risk assessments and contributed to investment decisions for early-stage programs by evaluating competitive landscape, resource needs, and projected outcomes.

Postdoctoral Research Scientist Biomarker and Translational Research Unit

EMD Serono
12.2015 - 04.2018
  • Conducted in-depth data analysis to identify key indicators of performance and resistance in 3 therapeutic candidates, informing critical development and investment decisions.
  • Led the creation of a comprehensive data package that enabled the launch of EMD Serono’s first clinical trial in hematological malignancies—demonstrating strong project ownership and outcome-driven execution.
  • Collaborated with cross-functional teams to translate complex scientific findings into strategic insights, directly contributing to go/no-go decisions on pipeline assets.
  • Provided actionable recommendations to leadership by synthesizing large datasets into clear, decision-ready intelligence aligned with organizational goals.

Postdoctoral Fellow

Dana Farber Cancer Institute
04.2014 - 08.2016
  • Performed in-depth evaluation of therapeutic strategies that informed the strategic development of targeted treatments.
  • Led research initiatives that directly enabled the initiation of Phase I oncology trials—demonstrating ability to translate data into high-impact clinical and business outcomes.
  • Designed and implemented data-driven strategies to assess synergistic drug combinations, expanding opportunities in previously underserved market segments.

Education

MBA - Business Analytics

Isenberg School of Management - U Mass Amherst
Amherst, MA
08.2027

PhD - Pharmacology

Universite De Montreal
Montreal, QC, Canada
08.2014

Skills

  • Strategic planning and decision-making
  • Problem-solving and analytical thinking
  • Data analysis and visualization
  • Stakeholder engagement and management
  • People management and mentorship
  • Project/Program management
  • Creativity and innovation
  • Contract and vendor management
  • Partnerships and alliances
  • Cross-functional team leadership

Certification

  • Finance & Quantitative Modeling, University of Pennsylvania - Ongoing
  • Applied Data Science, IBM - Ongoing
  • Data Analytics, Google- April 2025

Timeline

Director of Biology

Serna Bio
07.2024 - 02.2025

Scientific Director of Cancer Biology

Ikena Oncology
11.2021 - 12.2024

Principal Scientist Discovery, Research, and Evaluation

Corbus Pharmaceuticals
04.2021 - 11.2021

Principal Scientist Immune Oncology

Bicycle Therapeutics
04.2018 - 04.2021

Postdoctoral Research Scientist Biomarker and Translational Research Unit

EMD Serono
12.2015 - 04.2018

Postdoctoral Fellow

Dana Farber Cancer Institute
04.2014 - 08.2016

MBA - Business Analytics

Isenberg School of Management - U Mass Amherst

PhD - Pharmacology

Universite De Montreal

Similar Profiles

CREATE PROFILE
Eric Haines